ots Ad hoc-Service: STRATEC Biomedical Sys. <DE0007289001> STRATEC Biomedical Systems AG Concludes Development and Supply Agreement with the Akzo Nobel Subsidiary Organon Teknika
Birkenfeld (ots Ad hoc-Service) -
The sender is solely responsible for the contents of this announcement.
STRATEC Biomedical Systems AG Birkenfeld (WKN 728900) is one of the leading suppliers of automated systems for bioanalytical and diagnostics applications.
STRATEC Biomedical Systems AG has signed a development and supply agreement with Organon Teknika B.V., the Netherlands. Subject matter of this agreement is the development and thereafter subsequent delivery of fully automated high throughput systems based on STRATEC's PlateRunner system platform for a period of several years.
Organon Teknika, one of the leading companies in the field of infectious disease diagnostics in blood banks expects to further strenghten its position in the market with this fully automated analyzer.
Regarding the time of product launch and the business volume, we have agreed with Organon Teknika to maintain confidentiality for competitive reasons. Based on this agreement, STRATEC Biomedical Systems AG expects an not insignificant expansion of its turnover in the coming years.
Organon Teknika will market the systems under its own brand name together with its reagents.
The conclusion of this major, long-term contract highlights the potential of the PlateRunner system platform and the performance of the STRATEC Biomedical Systems AG in the diagnostics and life sciences market.
STRATEC Biomedical Systems AG Board of Management
For further information, please contact: www.stratec-biomedical.de
ir@stratec-biomedical.de
or +49 (0) 7082 - 79 16 27
End of Message Internet: http://recherche.newsaktuell.de
Original-Content von: STRATEC Biomedical AG, übermittelt durch news aktuell